O
Organogenesis Holdings D
D
ORGO
4.09000
USD
0.07
(1.61%)
Market Open
Volume
19,858
EPS
0
Div Yield
-
P/E
-82
Market Cap
542,237,893
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Organogenesis Holdings
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.